Clinical Trials
33 trialsOPEN
Irish Research Radiation Oncology Group
Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
NSABP Foundation Inc
"InDACtion" vs "3+7" Induction in AML
European Organisation for Research and Treatment of Cancer - EORTC
AF CRT +/- Nimorazole in HNSCC
European Organisation for Research and Treatment of Cancer - EORTC
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
NSABP Foundation Inc
INTEGRATEIIa
Australasian Gastro-Intestinal Trials Group
CY25
National Research Center for Hematology, Russia
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
GOG Foundation
Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer
GOG Foundation
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer
GOG Foundation
DAHANCA30
Danish Head and Neck Cancer Group
AdRad
Scandinavian Prostate Cancer Group
H10
European Organisation for Research and Treatment of Cancer - EORTC
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
GOG Foundation
MAXDARA
Grupo de Estudos Multicentricos em Onco-Hematologia
R-BL-M-04 Versus R-(DA)-EPOCH and Autologous Stem Cells Transplantation in Patients With High-Grade B-cell Lymphoma Double-hit (HGBL DH) and High-Grade B-cell Lymphoma Not Otherwise Specified (HGBL NOS)
National Research Center for Hematology, Russia
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
GOG Foundation
Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
NSABP Foundation Inc
SURTIME
European Organisation for Research and Treatment of Cancer - EORTC
Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer
European Organisation for Research and Treatment of Cancer - EORTC
R-Dose-adjusted (DA) - EPOCH-21 Versus R-modified Non-Hodgkin Lymphoma (NHL)-Berlin-Frankfurt-Munster (BFM)-90 Program (mNHL-BFM-90) and Autologous Stem Cells Transplantation (Auto-SCT) in DLBCL With Poor Prognosis
National Research Center for Hematology, Russia
A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
NSABP Foundation Inc
Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer
NSABP Foundation Inc
BRiF
National Research Center for Hematology, Russia
Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma
European Organisation for Research and Treatment of Cancer - EORTC
Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor
European Organisation for Research and Treatment of Cancer - EORTC
Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Years
Grupo de Estudos Multicentricos em Onco-Hematologia
TGOCphaseIII
Thai Gynecologic Oncology Collaborative Group
AIvsAD
Cooperative Study Group A for Hematology
Preoperative Radiotherapy and Local Excision in Rectal Cancer
Polish Colorectal Cancer Study Group
The Randomised Study of Preoperative Radiotherapy With Consolidating Chemotherapy for Unresectable Rectal Cancer
Polish Colorectal Cancer Study Group
Study in Myeloma Patients Newly Diagnosed Treated as an Induction With Velcade-Dex or Velcade (Bortezomib) Thalidomide Dexamethasone (VTD)
Intergroupe Francophone du Myelome
GIP-1
Istituti Tumori Giovanni Paolo II